GLAND PHARMA LTD FDA Approval ANDA 205323

ANDA 205323

GLAND PHARMA LTD

FDA Drug Application

Application #205323

Documents

Letter2017-02-08

Application Sponsors

ANDA 205323GLAND PHARMA LTD

Marketing Status

Prescription001
Prescription002

Application Products

001INJECTABLE;INJECTION5,000 UNITS/ML0HEPARIN SODIUMHEPARIN SODIUM
002INJECTABLE;INJECTION1,000 UNITS/ML0HEPARIN SODIUMHEPARIN SODIUM

FDA Submissions

UNKNOWN; ORIG1AP2017-02-06STANDARD

Submissions Property Types

ORIG1Null1

TE Codes

001PrescriptionAP
002PrescriptionAP

CDER Filings

GLAND PHARMA LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 205323
            [companyName] => GLAND PHARMA LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"HEPARIN SODIUM","activeIngredients":"HEPARIN SODIUM","strength":"5,000 UNITS\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"HEPARIN SODIUM","activeIngredients":"HEPARIN SODIUM","strength":"1,000 UNITS\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"02\/06\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/205323Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"11\/20\/2019","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2019-11-20
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.